Evidence map›Paper›PMID 33946749›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Universal Detection of Mi

Meng-Hua Yang, Jen-Wei Chen, Kaito Sayaka, Makoto Uchikawa, Nelson H Tsuno, Sheng-Tang Wei, Sheng-Mou Hou, Yann-Jang Chen

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Meng-Hua YangHead Office, Taiwan Blood Services Foundation, Taipei 10066, Taiwan.ORCID 0000-0001-9280-0803
Jen-Wei ChenHead Office, Taiwan Blood Services Foundation, Taipei 10066, Taiwan.
Kaito SayakaLaboratory Department, Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo 135-8639, Japan.
Makoto UchikawaLaboratory Department, Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo 135-8639, Japan.
Nelson H TsunoLaboratory Department, Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo 135-8639, Japan.ORCID 0000-0002-7619-6500
Sheng-Tang WeiHead Office, Taiwan Blood Services Foundation, Taipei 10066, Taiwan.
Sheng-Mou HouHead Office, Taiwan Blood Services Foundation, Taipei 10066, Taiwan.
Yann-Jang ChenInstitute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.
Japanese Red Cross Society, Japan · JPTaiwan Public Television Service Foundation · TWNational Yang Ming Chiao Tung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycophorin hybrids such as GP.Mur are common in Southeast Asians. In Taiwan, clinically significant alloantibodies to the GP.Mur phenotype are the most important issue in blood banks. A large-scale screening of glycophorin hybrids in the Taiwanese population is urgently needed to ensure transfusion safety. Four clones of human hybridomas that secrete anti-Mi

Indexed as

glycophorin hybridshuman hybridomaMia antigenMur antigenMUT antigen

Identifiers

PMID33946749
PMCPMC8146793
OpenAlexW3158620879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.